Integration of high throughput multi-omics datasets enables comprehensive exploration of disease landscape. We integrate multi-omics datasets and existing literature knowledge to represent disease mode of action. A detailed understanding of drug mechanism of action based on Pharmacokinetic (PK) and pharmacodynamic (PD) modeling helps in  expediting drug development. We offer services in target identification, target validation, drug mode of action(PK/PD modelling), biomarker discovery, and desiging patient stratification strategies leading to inclusion/exclusion criteria in clinical trials. 

Metagenomics delves into the genetic material of entire microbial communities, transcending the study of individual microorganisms. By analyzing the collective DNA of bacteria, viruses, and other microbes present in a given environment. We aim to better understand microbial diversity and functionality, unlocking insights into environmental, human gut. We also offer NGS based quality control services for biologics and vaccines. We are expert in metagenomics and represented GSK vaccines at FDA/PDA consortium on NGS based adventitious agents detection framework.

Nutrigenomics explores how specific genes influence body's reaction to various dietary components, paving way for personalized nutrition. By deciphering genetic variations at individual level, we aim to provide insights for optimized diet based on an individual's unique genetic profile. Nutrigenomics can revolutionize human wellness, utilizing genetic level insights ushering a new era of preventive healthcare. We strongly believe in sustainable human footprint on the planetary ecosystem. We are looking for potentail partners to have impact on food biotech or biofuel  industries.